首页|热毒宁注射液联合雾化吸入布地奈德混悬液对慢性支气管炎急性发作期患者的影响

热毒宁注射液联合雾化吸入布地奈德混悬液对慢性支气管炎急性发作期患者的影响

扫码查看
目的 探讨分析热毒宁注射液联合雾化吸入布地奈德混悬液对慢性支气管炎急性发作期患者临床症状和炎症因子水平的影响。方法 选取2019年1月至2023年8月新郑华信民生医院收治的60例慢性支气管炎急性发作期患者,根据随机数表法将患者分为对照组(给予雾化吸入用布地奈德混悬液治疗)和联合组(在对照组的基础上使用热毒宁注射液),每组患者各 30 例,两组均持续治疗 7 d,比较两组患者的临床疗效,治疗后临床症状的改善时间,治疗前后的血清炎症因子水平变化,血气指标及不良反应。结果 联合组治疗有效率(93。33%)高于对照组(73。33%),差异有统计学意义(P<0。05);联合组发热、呼吸困难、气喘咳嗽、肺部X线炎性吸收症状改善时间显著短于对照组,差异有统计学意义(P<0。05);治疗 7 d后,联合组的血清炎症因子水平显著低于对照组,差异有统计学意义(P<0。05);治疗 7 d后,联合组的动脉血氧分压(PaO2)、血氧饱和度(SaO2)水平显著高于对照组,动脉二氧化碳分压(PaCO2)显著低于对照组,差异有统计学意义(P<0。05);联合组不良反应的发生率(13。33%)与对照组(16。67%)比较,差异无统计学意义(P>0。05)。结论 热毒宁注射液联合雾化吸入用布地奈德混悬液治疗慢性支气管炎急性发作期患者具有较好的临床疗效,能明显减轻患者体内的炎症反应,改善血气指标,缩短症状改善时间。
The Impact of Reduning Injection Combined with Nebulized Budesonide Suspension on Patients with Acute Exacerbation of Chronic Bronchitis
Objective To analyze the effect of Reduning Injection combined with nebulized budesonide suspension on the clinical symptoms and inflammatory factor levels of patients with acute exacerbation of chronic bronchitis.Methods From January 2019 to August 2023,60 patients with acute exacerbation of chronic bronchitis treated in Xinzheng Huaxin Minsheng Hospital were selected.According to the random number table method,the patients were divided into a control group(given nebulized budesonide suspension treatment)and a combination group(using Reduning Injection on the basis of the control group),with 30 patients in each group.Both groups were treated continuously for 7 days.The clinical efficacy of the two groups of patients,the improvement time of clinical symptoms after treatment,the changes in serum inflammatory factor levels before and after treatment,blood gas indicators,and adverse reactions were compared.Results The treatment effectiveness rate of the combination group(93.33%)was higher than that of the control group(73.33%),and the difference was statistically significant(P<0.05);the improvement time of fever,dyspnea,wheezing cough,and pulmonary X-ray inflammatory absorption symptoms in the combination group was significantly shorter than that in the control group,and the difference was statistically significant(P<0.05);after 7 days of treatment,the serum inflammatory factor level of the combination group was significantly lower than that of the control group,and the difference was statistically significant(P<0.05);after 7 days of treatment,the arterial oxygen partial pressure(PaO2)and oxygen saturation(SaO2)levels of the combination group were significantly higher than those of the control group,and the partial pressure of carbon dioxide(PaCO2)was significantly lower than that of the control group,and the difference was statistically significant(P<0.05);the incidence rate of adverse reactions in the combination group(13.33%)was compared with the control group(16.67%),and the difference was not statistically significant(P>0.05).Conclusion Reduning Injection combined with nebulized budesonide suspension treatment for patients with acute exacerbation of chronic bronchitis has a good clinical effect,can significantly reduce the inflammatory response in the patient's body,improve blood gas indicators,and shorten the symptom improvement time.

Reduning Injectionnebulized budesonide suspensionacute exacerbation of chronic bronchitisclinical symptomsinflammatory factors

刘剑、冯二香、徐伟利

展开 >

新郑华信民生医院 呼吸内科,河南 郑州 451100

热毒宁注射液 雾化吸入用布地奈德混悬液 慢性支气管炎急性发作期 临床症状 炎症因子

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(8)